Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Ibrahim Mamane Lawan"'
Autor:
Mahamadou Bassirou Souleymane, Tom Decroo, Saïdou Mamadou, Alphazazi Soumana, Ibrahim Mamane Lawan, Assiatou Gagara-Issoufou, Eric Adehossi, Nimer Ortuño-Gutiérrez, Lutgarde Lynen, Leen Rigouts, Bouke Catherine de Jong, Armand Van Deun, Alberto Piubello
Publikováno v:
International health
Background Outcomes of retreatment for rifampicin-resistant tuberculosis (RR-TB) are rarely reported. We report ‘definitive outcomes’ after a cascade approach to RR-TB treatment. After a bacteriologically adverse outcome for the 9-months fluoroqu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b986dd426f3554aa2363885e8344eb95
https://doi.org/10.1093/inthealth/ihac016
https://doi.org/10.1093/inthealth/ihac016
Autor:
Lutgarde Lynen, Nimer Ortuno-Gutierrez, Bouke C. de Jong, Alberto Roggi, Mourtala Mohamed Assao-Neino, Tom Decroo, Alphazazi Soumana, Mahamadou Bassirou Souleymane, Saidou Mamadou, Assiatou Gagara-Issoufou, Souleymane Hassane-Harouna, Ibrahim Mamane Lawan, Armand Van Deun, V Schwoebel, Zelika Hamidou-Harouna, Alberto Piubello
Publikováno v:
The European respiratory journal. 57(1)
The short treatment regimen (STR) achieves a >80% cure in rifampicin-resistant tuberculosis (RR-TB) patients. However, ototoxicity induced by the injectable is a concern. This is the first study to evaluate the replacement of injectables by linezolid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ea99bf523e3be1ea191c077683bbc58
https://pubmed.ncbi.nlm.nih.gov/32703777
https://pubmed.ncbi.nlm.nih.gov/32703777